Edwards Lifesciences Corp (NYSE:EW)
| 82.77 Delayed Data As of Sep 30 |  -1.06 / -1.26%Today’s Change | 81.87 Today|||52-Week Range 131.73 | -36.11% Year-to-Date |
Latest EW News | Press Releases
No recent news for Edwards Lifesciences Corp.
Today’s Trading
| Previous close | 83.83 |
| Today’s open | 84.26 |
| Day’s range | 82.51 - 85.81 |
| Volume | 2,726,086 |
| Average volume (3 months) | 2,632,414 |
| Market cap | $52.5B |
Data as of 4:02pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +82.34% |
| Earnings growth (this year) | +13.14% |
| Earnings growth (next 5 years) | +11.93% |
| Revenue growth (last year) | +19.29% |
| P/E ratio | 35.8 |
| Price/Sales | 15.63 |
| Price/Book | 9.06 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ISRGIntuitive Surgical | -1.61 | -0.85% |
| SYKStryker Corp | +0.41 | +0.20% |
| STESTERIS plc | +0.31 | +0.19% |
| ---- |
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | October 26, 2022 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $5.2B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 28.73% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
